Overactive Bladder - Results from #1180

Patient-Reported Outcomes With the b3-Adrenoceptor Agonist Mirabegron in a Phase III Trial in Patients With Overactive Bladder February 26, 2017

The effect of sacral neuromodulation on pregnancy: a systematic review February 13, 2017

Solifenacin in the Elderly: Results of an Observational Study Measuring Efficacy, Tolerability and Cognitive Effects February 6, 2017

Assessment of voiding dysfunction in Parkinson's disease: Reliability and validity of the Turkish version of the Danish Prostate Symptom Score February 6, 2017

Parasacral transcutaneous electrical neural stimulation (PTENS) once a week for the treatment of overactive bladder in children: A randomized controlled trial February 6, 2017

Effect of Trospium Chloride on Cognitive Function in Women Aged 50 and Older: A Randomized Trial February 6, 2017

The Problem of Polypharmacy in Female Patients with Overactive Bladders - Cross-Sectional Study in a Specialist Outpatient Department February 6, 2017

B3-Adrenoceptor Control Of Lower Genıtourınary Tract Organs And Functıon In Male: An Overvıew. February 1, 2017

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice February 1, 2017

Investigation of piperazine benzamides as human β3 adrenergic receptor agonists for the treatment of overactive bladder. February 1, 2017

Comorbidity between idiopathic overactive bladder and chronic migraine January 29, 2017

Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study January 29, 2017

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment January 24, 2017

The effect of posture and repetition on urodynamic parameters: A prospective randomized study January 24, 2017

Treatment of Concomitant OAB and BPH January 24, 2017

Anticholinergic prescription: are healthcare professionals the real burden? January 24, 2017

Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls January 24, 2017

Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment? January 1, 2017

Mirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder populations and patients with OAB in Asia December 26, 2016

A clinical perspective on electronically collecting patient-reported outcomes at the point-of-care for overactive bladder December 26, 2016

Page 60 of 122